Related Experiment Video

Updated: Mar 7, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Dopa-Responsive Balance Changes Depend on Use of Internal Versus External Attentional Focus in Parkinson Disease

Eric N Beck, Quincy J Almeida

    Physical Therapy
    |February 17, 2017
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021

    3.6K
    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    16.4K

    Related Experiment Videos

    Last Updated: Mar 7, 2026

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
    07:26

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

    Published on: September 26, 2019

    8.4K
    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021

    3.6K
    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    16.4K

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    1.3K
    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.3K
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    2.3K
    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
    2.3K
    Neural Regulation01:37

    Neural Regulation

    43.9K
    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    43.9K

    Articles linked to this work by shared authors, journal, and citation graph.

    Dementia Care Research and Psychosocial Factors.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Public Health.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Synergistic effects of exercise, cognitive training and vitamin D on gait performance and falls in mild cognitive impairment-secondary outcomes from the SYNERGIC trial.

    Age and ageing·2025

    The Role of Functional Brain Connectivity in Intervention Success: A Secondary Analysis from the SYNERGIC Trial.

    Medicine and science in sports and exercise·2025

    Exploring Motor-Cognitive Interference Effects and the Influence of Self-Reported Physical Activity on Dual-Task Walking in Parkinson's Disease and Healthy Older Adults.

    Brain sciences·2025

    Evaluating the Effectiveness of an Integrated Treatment of Vestibular Rehabilitation and Cognitive Behavior Therapy for Chronic Dizziness in a Community-Based Population: A Randomized Controlled Trial.

    Physical therapy·2026

    Biomechanical Contributions to Alterations in Peak Metabolic Capacity and Efficiency Following Locomotor Training in Individuals After Stroke.

    Physical therapy·2026

    Impact of Social Determinants of Health on Physical Therapy Utilization in Home Health and Outpatient Settings: A Retrospective Cohort Study.

    Physical therapy·2026

    Characteristics of Outpatient Care Settings Associated with Implementation Outcomes for a Group Physical Therapy Program.

    Physical therapy·2026

    The Role of Physical Activity in Oral Cancer Recovery:A Systematic Review.

    Physical therapy·2026

    Severity of Structural Lumbar Spinal Stenosis Does Not Impact Responsiveness to Exercise-Based Rehabilitation.

    Physical therapy·2026

    The shake-test for adjuvanted vaccines: A manufacturer's perspective.

    Journal of pharmaceutical sciences·2026

    Zhangyanming Tablets for Dry Eye Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.

    Chinese journal of integrative medicine·2026

    Doravirine/Islatravir: First Approval.

    Drugs·2026

    Proteolysis Targeting Chimeras (PROTACs): Design and Mechanism.

    Handbook of experimental pharmacology·2026

    PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs.

    Handbook of experimental pharmacology·2026

    High-Throughput Screen for Candidate PROTAC Identification.

    Handbook of experimental pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us